Completed
Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
NCT00619489
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +8 more
- Locations
-
- London Health Sciences Centre London, Ontario, Canada